ArticleCase reports in oncological medicine2016

Durable Clinical Benefit of Pertuzumab in a Young Patient with BRCA2 Mutation and HER2-Overexpressing Breast Cancer Involving the Brain.

Anna Koumarianou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.